| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $357.7M | +29.4% |
| Operating Income | -$509.7M | -14.1% |
| Pre-tax Income | -$536.6M | -17.3% |
| Income Tax | $200K | -60.0% |
| Net Income | -$536.8M | -17.2% |
| EPS (Basic) | -$1.42 | +16.0% |
| EPS (Diluted) | -$1.42 | +16.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $834.5M | +79.6% |
| Short-term Investments | $0 | — |
| Current Assets | $858.4M | +78.8% |
| Total Assets | $1.00B | +80.6% |
| Current Liabilities | $71.1M | -37.6% |
| Long-term Debt | $64.0M | +788.9% |
| Total Liabilities | $248.6M | +32.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$368.6M | -35.7% |
| Capital Expenditures | $82.0M | +85.1% |
| Investing Cash Flow | -$82.0M | -119.5% |
| Financing Cash Flow | $820.4M | +228.0% |
| Free Cash Flow | -$450.6M | -42.6% |
| Stockholders' Equity |
| $752.6M |
| +105.0% |